PCRX Competitors & Alternatives

Compare Pacira BioSciences, Inc. with similar stocks in the same industry

Drug Manufacturers - Specialty & Generic

PCRX

Main Stock
$25.36
Tradestie Score
48
Market Cap
$1.14B
P/E Ratio
74.0
Revenue Growth
0.1%
Analyst Upside
+18.3%

Top Competitors

44 stocks in Drug Manufacturers - Specialty & Generic
Company Price Market Cap P/E Score Action
AVDL Avadel Pharmaceuticals plc Ordinary Share
$21.64
$1.46B - 48 Compare
EVO Evotec SE American Depositary Shares
$1.73
$1.34B - 42 Compare
XERS Xeris Biopharma Holdings, Inc. Common Stock
$7.45
$1.29B - 47 Compare
AMPH Amphastar Pharmaceuticals, Inc.
$23.78
$1.25B 13.9 34 Compare
DVAX Dynavax Technologies Corporation
$15.50
$1.21B - 48 Compare
COLL Collegium Pharmaceutical, Inc. Common Stock
$22.75
$1.11B 18.3 46 Compare
CRON Cronos Group Inc. Common Share
$3.14
$1.02B 16.6 48 Compare
AQST Aquestive Therapeutics, Inc. Common Stock
$4.78
$711.32M - 40 Compare
ESPR Esperion Therapeutics, Inc.
$3.18
$584.71M - 53 Compare
ETON Eton Pharmaceutcials, Inc. Common Stock
$57.08
$543.32M 152.3 43 Compare

Data updated: Sep 12, 2026 | Industry: Drug Manufacturers - Specialty & Generic (SIC 2834)

44 stocks in this industry